Loading clinical trials...
Loading clinical trials...
Surgical Staging for the Treatment of Endometrial Cancer Based on IOC
Complete pelvic and para-aortic lymphadenectomy performed at the time of primary surgical staging for endometrial cancer increases operative time and surgical morbidity, but appears to be necessary in most high grade and deeply invasive cancers. To date, the Mayo Clinic approach has not been reproduced, and the investigators propose to validate their algorithm at the University of Kentucky utilizing intra-operative consultation (IOC). The preliminary data at the University of Kentucky for IOC and endometrial cancer outcomes suggest that the investigators are well-suited to perform this investigation. A surgical approach that is tailored to the patient's cancer biology is rational, supported by the recent literature, and medically compelling since the co-morbidities of many obese, low-risk EC patients put them at significantly increased perioperative risk for complete lymphadenectomy.
Age
18 - 100 years
Sex
FEMALE
Healthy Volunteers
No
University of Kentucky
Lexington, Kentucky, United States
Start Date
January 29, 2016
Primary Completion Date
December 8, 2023
Completion Date
November 1, 2026
Last Updated
January 22, 2026
401
ACTUAL participants
Lymphadenectomy
PROCEDURE
Lead Sponsor
Frederick R. Ueland, M.D.
NCT05489211
NCT04657068
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions